• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性粒细胞白血病和淋巴瘤患者的端粒酶活性

Telomerase activity in patients with chronic myeloid leukemia and lymphoma.

作者信息

Bitisik O, Yavuz S, Yasasever V, Dalay N

机构信息

Istanbul University, Oncology Institute, Dept. of Basic Oncology.

出版信息

Res Commun Mol Pathol Pharmacol. 2000;107(1-2):3-12.

PMID:11334367
Abstract

Telomeres are repeated DNA sequences, positioned at the ends of chromosomes and are essential for the stable maintenance of chromosomes. The telomere length serves as a mitotic clock determining the remaining replicative capacity of the cell. Telomeric sequences are lost during each cell division, leading to a process thought to contribute to senescence and cell death. The enzyme telomerase adds 5'-TTAGGG-3' repeats to the mammalian telomeres and maintains the telomere length. Telomerase is normally inactive in most somatic cells but telomerase activity is observed in malignancies. In this study telomerase activity was analyzed in patients with chronic myeloid leukemia (CML) and lymphoma by PCR and ELISA. This approach combines highly specific amplification of the telomerase-mediated elongation products with nonradioactive detection in a highly sensitive photometric ELISA. The PCR products were also analyzed by Southern blotting. The telomerase-specific PCR products were seperated by electrophoresis and transferred to a nylon membrane with subsequent detection of the biotinylated amplificates. High activity levels were detected in 17 CML ( 34%) patients. On the other hand, no activity was observed in lymphoma patients. An increase in the shorter telomeric bands was observed in CML patients who displayed a high level of telomerase activity. In contrast to the low enzyme activity, evidence of telomeric repeats were also found in some lymphoma patients by Southern blotting. This may indicate that lymphoma cells may make use of different pathways for maintaining the length of their telomeres.

摘要

端粒是位于染色体末端的重复DNA序列,对染色体的稳定维持至关重要。端粒长度充当有丝分裂时钟,决定细胞剩余的复制能力。端粒序列在每次细胞分裂过程中都会丢失,导致一个被认为与衰老和细胞死亡有关的过程。端粒酶将5'-TTAGGG-3'重复序列添加到哺乳动物端粒上,并维持端粒长度。端粒酶在大多数体细胞中通常无活性,但在恶性肿瘤中可观察到端粒酶活性。在本研究中,通过聚合酶链反应(PCR)和酶联免疫吸附测定(ELISA)分析了慢性粒细胞白血病(CML)和淋巴瘤患者的端粒酶活性。这种方法将端粒酶介导的延伸产物的高度特异性扩增与高灵敏度光度ELISA中的非放射性检测相结合。PCR产物也通过Southern印迹法进行分析。端粒酶特异性PCR产物通过电泳分离,转移到尼龙膜上,随后检测生物素化的扩增产物。在17例(34%)CML患者中检测到高活性水平。另一方面,在淋巴瘤患者中未观察到活性。在表现出高水平端粒酶活性的CML患者中,观察到较短端粒条带增加。与低酶活性相反,通过Southern印迹法在一些淋巴瘤患者中也发现了端粒重复序列的证据。这可能表明淋巴瘤细胞可能利用不同途径来维持其端粒长度。

相似文献

1
Telomerase activity in patients with chronic myeloid leukemia and lymphoma.慢性粒细胞白血病和淋巴瘤患者的端粒酶活性
Res Commun Mol Pathol Pharmacol. 2000;107(1-2):3-12.
2
Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.皮肤T细胞淋巴瘤患者淋巴细胞中的端粒酶活性与端粒长度
Cancer. 1999 Sep 15;86(6):1056-63.
3
Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.慢性髓系白血病中的端粒与端粒酶:对发病机制、疾病进展及靶向治疗的影响
Hematol Oncol. 2009 Sep;27(3):123-9. doi: 10.1002/hon.901.
4
Telomerase activity in myelodysplastic syndromes.骨髓增生异常综合征中的端粒酶活性
Leuk Res. 2005 Oct;29(10):1131-9. doi: 10.1016/j.leukres.2005.03.006. Epub 2005 Apr 7.
5
Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.急性和慢性白血病在体外培养前后的端粒酶活性和端粒长度
Cancer Res. 2000 Feb 1;60(3):610-7.
6
[Telomeres, telomerase and development of cancer].[端粒、端粒酶与癌症的发展]
Tidsskr Nor Laegeforen. 1998 May 20;118(13):2043-6.
7
Telomeres and telomerase in leukaemia and lymphoma.白血病和淋巴瘤中的端粒与端粒酶
Transfus Apher Sci. 2007 Aug;37(1):43-7. doi: 10.1016/j.transci.2007.04.006. Epub 2007 Sep 4.
8
In vivo regulation of telomerase activity and telomere length.端粒酶活性和端粒长度的体内调节。
Immunol Rev. 2005 Jun;205:104-13. doi: 10.1111/j.0105-2896.2005.00267.x.
9
Multiple pathways for the regulation of telomerase activity.端粒酶活性调控的多种途径。
Eur J Cancer. 1997 Apr;33(5):761-6. doi: 10.1016/S0959-8049(97)00066-X.
10
Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.端粒长度和端粒酶活性可预测B细胞慢性淋巴细胞白血病患者的生存期。
Cancer Res. 1998 Nov 1;58(21):4918-22.

引用本文的文献

1
Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.癌症流行病学中选定新兴技术的机遇与挑战:线粒体、表观基因组学、代谢组学和端粒酶谱分析。
Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):189-200. doi: 10.1158/1055-9965.EPI-12-1263. Epub 2012 Dec 14.